Island Sweet Skunk CBD
Skunk #1 × Grapefruit × Sweet Pink Grapefruit
Island Sweet Skunk (CBD) is an indica-dominant hybrid originating from British Columbia's craft cannabis scene. This cultivar is a CBD-forward variation of the original Island Sweet Skunk, developed to offer functional, uplifting effects. It is recognized for its distinct tropical and skunky aroma profile.
Appearance
This strain typically exhibits a sativa-leaning plant structure, characterized by its tall, graceful frame with elongated internodes and narrow leaflets. It develops an upright growth habit, often stretching significantly during the flowering period. The plant displays a lime-to-emerald green coloration, accented by bright orange pistils and a liberal dusting of silvery trichomes.
The buds tend to form conical shapes, sometimes with slight foxtailing, especially under intense light or warmer temperatures. Compared to denser indica flowers, Island Sweet Skunk's colas are moderately dense and possess a high calyx-to-leaf ratio, which can simplify the trimming process. Mature flowers are often covered in a generous layer of trichomes.
Aroma & Flavor
The aroma of Island Sweet Skunk (CBD) is a complex blend of tropical fruit and classic skunk. Initial notes are bright and tangy, featuring scents of grapefruit, mango, and sweet orange when the flowers are handled. Underlying these fruity top notes is a grounding skunky musk, often accompanied by hints of pine and pepper, creating a layered aromatic profile.
Upon consumption, the flavor mirrors the aroma, presenting a vivid taste of ripe mango, pink grapefruit, and sugarcane. A subtle skunky or musky undertone balances the sweetness, while notes of pine and pepper contribute to a crisp finish. The aftertaste is typically clean, sweet, and mildly resinous.
Effects
Island Sweet Skunk (CBD) is noted for its energizing and uplifting effects, making it a popular choice for daytime use. It is often described as a wake-and-bake option that can help motivate users and combat feelings of fatigue. The CBD-rich variant aims to provide these functional benefits while maintaining a clear-headed experience.
Terpenes & Cannabinoids
While specific cannabinoid percentages can vary, the CBD variant of Island Sweet Skunk is bred to have a notable CBD content, often in a balanced ratio with THC. Dominant terpenes reported in some batches include myrcene, pinene, and caryophyllene, contributing to its characteristic aroma and flavor profile. Other terpenes like geraniol have also been identified, adding floral and candied nuances.
Growing
Island Sweet Skunk (CBD) is generally considered a sativa-dominant plant with a tall, lanky growth habit that can double in height during flowering. Its structure, with airy foliage, promotes good airflow, potentially reducing the risk of pests and mold. The plant's morphology lends itself well to techniques like SCROG (Screen of Green) and lateral training.
Historically, the strain has been known for moderate yields rather than heavy harvests, contributing to its reputation as a connoisseur's choice. However, modern cultivation methods and the development of CBD-rich versions have aimed to improve its yield potential while maintaining its desirable traits. It is often described as having a favorable calyx-to-leaf ratio, which can make trimming more efficient.
Origins & Lineage
Island Sweet Skunk (CBD) traces its origins to the craft cannabis scene of Vancouver Island, British Columbia. The original Island Sweet Skunk, developed in the late 1990s and early 2000s, was a refined Skunk expression favored for its clarity and daytime suitability. The CBD variant emerged later through selective breeding or crosses with high-CBD donor lines, aiming to enhance cannabidiol levels while preserving the cultivar's signature characteristics.
The genetic lineage of the classic Island Sweet Skunk is widely believed to be a cross between Skunk #1 and a sweet, citrus-forward clone, often linked to Grapefruit or Sweet Pink Grapefruit. This combination amplifies Skunk #1's vigor and resin production, adding a tropical-citrus profile and a more sativa-leaning effect. The CBD version was developed by Canadian licensed producers to meet medical demand for non-sedating, functional options.